# Exenatide with dapagliflozin: kidney markers in DECREASE

Source: https://pepvault.app/research/exenatide-decrease-2021

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Exenatide](https://pepvault.app/research#exenatide)

Randomized trial · people

# Exenatide plus dapagliflozin: UACR fell 39.6% vs 11.0% on placebo

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this trial, exenatide alone did not clearly change kidney markers over 16 weeks. Pairing it with dapagliflozin showed a larger drop in urine albumin from baseline, but that drop was not statistically significant against placebo.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 66
- **Published:** 2021
- **Journal:** Diabetes Obes Metab

## What they tested

The team tested whether exenatide twice daily, the diabetes drug dapagliflozin, or both together change markers of kidney function in obese people with type 2 diabetes.

## How the study was done

This was a planned secondary analysis of a 16-week randomized, double-blind, placebo-controlled trial in 66 obese people with type 2 diabetes. Groups got exenatide, dapagliflozin, both, or placebo (a dummy treatment).

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 16, UACR (the albumin-to-creatinine ratio in 24-hour urine) changed from baseline by -39.6% with the combination (P = 0.001), -18.1% with dapagliflozin, -15.6% with exenatide alone and -11.0% with placebo, and only the combination's change was statistically significant. Against placebo, the combination's UACR difference was -32.2% (P = 0.159), which was not statistically significant. The combination brought an early dip in estimated GFR, a measure of kidney filtering, of -10.4 mL/min/1.73 m2 by cystatin C (P < 0.001) and -4.0 mL/min/1.73 m2 by creatinine (P = 0.129), compared with placebo. Kidney injury molecule-1 relative to creatinine was 43.8% lower with the combination than with placebo (P = 0.129).

## What it doesn’t show

This was a small, 16-week secondary analysis that tracked lab markers, not kidney disease outcomes. The combination's edge over placebo on UACR was not statistically significant, so the authors' view that the two drugs work together is tentative.

## The paper

van Ruiten et al. Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial. Diabetes Obes Metab. 2021.

- [PubMed (PMID 33908691)](https://pubmed.ncbi.nlm.nih.gov/33908691/)
- [The paper (DOI 10.1111/dom.14410)](https://doi.org/10.1111/dom.14410)

## The compound

- [Exenatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## More studies on Exenatide

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024) Randomized trial · people · 2024
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023) Randomized trial · people · 2023
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022) Randomized trial · people · 2022
- [Exenatide: 29.2% spontaneous pregnancy vs 14.7% on metformin in PCOS](https://pepvault.app/research/exenatide-li-2022) Randomized trial · people · 2022
- [Exenatide, alone or with dapagliflozin, improved blood sugar in PCOS](https://pepvault.app/research/exenatide-elkind-hirsch-2021) Randomized trial · people · 2021
- [Exenatide ER: 0.9% HbA1c drop vs 1.5% with semaglutide in SUSTAIN 3](https://pepvault.app/research/exenatide-sustain-3-2018) Randomized trial · people · 2018
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

## The library

- [Exenatide](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
